Veterinary Medicine Information website

Milbenin 12.5 mg/125 mg chewable tablets for dogs

Authorised
  • Milbemycin oxime
  • Praziquantel

Product identification

Medicine name:
Milbenin 12.5 mg/125 mg chewable tablets for dogs
Active substance:
  • Milbemycin oxime
  • Praziquantel
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Milbemycin oxime
    12.50
    milligram(s)
    /
    1.00
    Tablet
  • Praziquantel
    125.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Chewable tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP54AB51
Authorisation status:
  • Valid
Authorised in:
  • Greece
Package description:
  • 2 or 4 tablets in OPA-Al-PVC/AL blisters. 12 blisters of 4 chewable tablets introduced in carton box.
  • 2 or 4 tablets in OPA-Al-PVC/AL blisters. 1 blister of 4 chewable tablets introduced in carton box.
  • 2 or 4 tablets in OPA-Al-PVC/AL blisters. 1 blister of 2 chewable tablets introduced in carton box.

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Pharma VIM Kft.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Vim Spectrum S.R.L.
Responsible authority:
  • National Organization For Medicines
Authorisation number:
  • 34700/10-04-2023/K-0251702
Date of authorisation status change:
Reference member state:
  • Hungary
Procedure number:
  • HU/V/0146/002
Concerned member states:
  • Belgium
  • France
  • Germany
  • Greece
  • Italy
  • Luxembourg
  • Netherlands
  • Portugal
  • Romania
  • Spain

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Greek (PDF)
Published on: 6/10/2025

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Greek (PDF)
Published on: 14/11/2024